186 related articles for article (PubMed ID: 10784544)
1. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
Mann RD; Pearce GL; Dunn N; Shakir S
BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
[TBL] [Abstract][Full Text] [Related]
2. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
de Abajo FJ; Rodríguez LA
Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
[TBL] [Abstract][Full Text] [Related]
3. Risks of non-sedating antihistamines.
Lindquist M; Edwards IR
Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
[No Abstract] [Full Text] [Related]
4. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA
Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513
[TBL] [Abstract][Full Text] [Related]
5. Safety of second generation antihistamines.
Philpot EE
Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
[TBL] [Abstract][Full Text] [Related]
6. Variations among non-sedating antihistamines: are there real differences?
Mattila MJ; Paakkari I
Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
Ballmer-Weber BK; Gex-Collet C; Wüthrich B
J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
9. The effects of antihistamines with varying anticholinergic properties on voluntary and involuntary movement.
Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
Clin Neurophysiol; 2013 Sep; 124(9):1840-5. PubMed ID: 23643576
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of new antihistamines and cisapride.
Paakkari I
Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
[TBL] [Abstract][Full Text] [Related]
11. Sedation from H1 antagonists: evaluation methods and experimental results.
Passalacqua G; Scordamaglia A; Ruffoni S; Parodi MN; Canonica GW
Allergol Immunopathol (Madr); 1993; 21(2):79-83. PubMed ID: 8101691
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
Spangler DL; Brunton S
South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
[TBL] [Abstract][Full Text] [Related]
13. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
15. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
O'Hanlon JF; Ramaekers JG
Allergy; 1995 Mar; 50(3):234-42. PubMed ID: 7677241
[TBL] [Abstract][Full Text] [Related]
16. Dangers of non-sedating antihistamines.
Cohen AT
Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217740
[No Abstract] [Full Text] [Related]
17. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
20. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
